|
顯示項目 728601-728610 / 2348971 (共234898頁)
<< < 72856 72857 72858 72859 72860 72861 72862 72863 72864 72865 > >>
每頁顯示[10|25|50]項目
| 元智大學 |
Jan-21 |
Results of a 200 hours lifetime test of a 7 kW Hybrid-Power fuel cell system on electric forklifts
|
Hsieh, C. Y. ; Bai, Q.; Ay Su; Fangbor Weng; Chi-Yuan Lee |
| 國立成功大學 |
2020 |
Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire
|
Coates, L.C.;Orbai, A.-M.;Azevedo, V.F.;Cappelleri, J.C.;Steinberg, K.;Lippe, R.;Lim, I.;Eder, L.;Richette, P.;Weng, M.Y.;Queiro, Silva R.;Fallon, L. |
| 國立成功大學 |
2014-11 |
Results of a phase I, open-label, multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary antitumour activity of AZD9150 in patients with advanced/metastatic hepatocellular carcinoma
|
Kang, Y. K.; Ryoo, BY; Kim, TY; Lee, KH; Lim, HY; Lee, SJ; Ikeda, M; Okusaka, T; Nadano, S; Lin, CC; Poon, TP; Yen, CJ; McCoon, P; Neumann, F; Vishwantahan, K; DuPont; Lyne, P |
| 臺大學術典藏 |
2018-09-10T15:25:07Z |
Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials
|
Kuo, H.-C. and Lin, H.-H. and Yu, H.-J. and Cheng, C.-L. and Hung, M.-J. and Lin, A.T.L.; HO-HSIUNG LIN; HONG-JENG YU |
| 臺大學術典藏 |
2020-02-17T08:50:53Z |
Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials
|
Lin A.T.L.; Hung M.-J; Cheng C.-L; Kuo H.-C; HO-HSIUNG LIN; Yu H.-J |
| 臺大學術典藏 |
2021-02-02T00:43:02Z |
Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials
|
Kuo H.-C.;Lin H.-H.;Hong-Jeng Yu;Cheng C.-L.;Hung M.-J.;Lin A.T.L.; Kuo H.-C.; Lin H.-H.; HONG-JENG YU; Cheng C.-L.; Hung M.-J.; Lin A.T.L. |
| 臺大學術典藏 |
2021-03-03T03:00:57Z |
Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials
|
Kuo H.-C.; HO-HSIUNG LIN; Yu H.-J.; Cheng C.-L.; Hung M.-J.; Lin A.T.L. |
| 臺大學術典藏 |
2020-03-06T03:42:42Z |
Results of An Implant Masking Integrated Workcall in A Development Facility
|
Griffin R.;Guo R.-S.;Slama M.; Griffin R.; Guo R.-S.; Slama M.; RUEY-SHAN GUO |
| 臺大學術典藏 |
2018-09-10T05:00:39Z |
Results of an Implant Masking Integrated Workcell in a Development Facility
|
RUEY-SHAN GUO; RUEY-SHAN GUO |
| 國立臺灣大學 |
1994 |
Results of Changing Cyclosporine From Twice to Once Daily Dosing Frequency
|
謝輝和; 陳鉅淮; 賴明坤; HSIEH, HWEI-HO; CHEN, CHU-HUAI; LAI, MING-KUEN |
顯示項目 728601-728610 / 2348971 (共234898頁)
<< < 72856 72857 72858 72859 72860 72861 72862 72863 72864 72865 > >>
每頁顯示[10|25|50]項目
|
